Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Colorectal Cancer Awareness in Turkey

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04020614
Recruitment Status : Recruiting
First Posted : July 16, 2019
Last Update Posted : July 16, 2019
Istanbul Training and Researh Hospital
Taksim Training and Research Hospital
Information provided by (Responsible Party):
Cemile Idiz, Istanbul University

Brief Summary:
Colorectal cancer is among the most common types of cancer worldwide. Population-based screening programs for breast, cervical, and colorectal cancer have been introduced as part of cancer control in many high-income countries. Population-based cancer screening programs do not exist in most low- and middle-income countries. There are some studies that report the awareness of colorectal cancer in Turkey.

Condition or disease Intervention/treatment
Colorectal Cancer Other: Survey

Detailed Description:
Colorectal cancer is the third most common type of cancer in both men and women. According to World Health Organization data, in 2012, 694 thousand people were thought to be due to colorectal cancer and this number increased to 862 thousand people in 2018. Especially in most low- and middle-income countries where cancers are mainly detected through very-late-stage symptoms and many are not reported. Recent researches may lead to new approaches to early detection and treatment using improved awareness of the symptomatic disease and population-based screening of asymptomatic people. The increasing of colorectal cancer awareness could help early detection of colorectal cancers. In this study, the investigators aimed to determine the level of awareness of colorectal cancer and knowledge about colorectal cancer screenings in patients who applied to general surgery outpatients clinic where a colorectal cancer diagnosis was most frequently diagnosed.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Assessment of Colorectal Cancer Awareness in Patients Admitted to the General Surgery Outpatient Clinic
Actual Study Start Date : May 1, 2019
Estimated Primary Completion Date : July 31, 2019
Estimated Study Completion Date : August 15, 2019

Group/Cohort Intervention/treatment
All of the patients that enrolled in this study will be in this group.
Other: Survey
A survey with 13 questions will be applied to the patients

Primary Outcome Measures :
  1. The awareness of patients about colorectal cancer [ Time Frame: 3 months ]
    To assess the awareness of patients about colorectal cancer with a survey

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Sampling Method:   Non-Probability Sample
Study Population
Patients who apply to the general surgery outpatient clinic with any diseases.

Inclusion Criteria:

  • Patients who apply to the general surgery outpatients clinic

Exclusion Criteria:

  • Younger than 18 years old
  • Older than 80 years old
  • Mental retardation or other mental illness
  • Refusing to join the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT04020614

Layout table for location contacts
Contact: Cemile Idiz, PhD +905367206668

Layout table for location information
Istanbul Training and Research Hospital Recruiting
Istanbul, Turkey, 34098
Contact: Coskun Cakir, MD    +905054405493   
Sponsors and Collaborators
Istanbul University
Istanbul Training and Researh Hospital
Taksim Training and Research Hospital
Layout table for investigator information
Study Director: Coskun Cakir, MD Istanbul Training and Research Hospital

Publications of Results:
Layout table for additonal information
Responsible Party: Cemile Idiz, Principal Investigator, Istanbul University Identifier: NCT04020614    
Other Study ID Numbers: Colorectal Cancer
First Posted: July 16, 2019    Key Record Dates
Last Update Posted: July 16, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: In case of request individual participant data could be shared with other researchers

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Cemile Idiz, Istanbul University:
Colorectal Cancer
Additional relevant MeSH terms:
Layout table for MeSH terms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases